Recommendations on the Clinical Application and Future Potential of α-Particle Therapy: A Comprehensive Review of the Results from the SECURE Project
This review comprehensively assesses the clinical applications and future potential of alpha-emitting radionuclides available for targeted alpha-particle therapy (TAT) in cancer treatment. The approval of radium-223 therapy in 2013 marked a significant advancement in alpha-emitting therapeutic radio...
| 出版年: | Pharmaceuticals |
|---|---|
| 主要な著者: | Valentina Di Iorio, Anna Sarnelli, Stefano Boschi, Maddalena Sansovini, Rosa Maria Genovese, Cipriana Stefanescu, Vlad Ghizdovat, Wael Jalloul, Jennifer Young, Jane Sosabowski, Petra Kolenc, Rachel Roberts, Govert de With, Dimitris Visvikis, Renata Mikolajczak |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
MDPI AG
2025-10-01
|
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/1424-8247/18/10/1578 |
類似資料
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”
著者:: Romain Eychenne, 等
出版事項: (2021-06-01)
著者:: Romain Eychenne, 等
出版事項: (2021-06-01)
Editorial: Targeted alpha particle therapy in oncology
著者:: Øyvind Sverre Bruland, 等
出版事項: (2023-03-01)
著者:: Øyvind Sverre Bruland, 等
出版事項: (2023-03-01)
Astatine-211 and actinium-225: two promising nuclides in targeted alpha therapy
著者:: Zuo Dashan, 等
出版事項: (2024-11-01)
著者:: Zuo Dashan, 等
出版事項: (2024-11-01)
Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications
著者:: Bryce J. B. Nelson, 等
出版事項: (2020-12-01)
著者:: Bryce J. B. Nelson, 等
出版事項: (2020-12-01)
Gamma counting protocols for the accurate quantification of 225Ac and 213Bi without the need for a secular equilibrium between parent and gamma-emitting daughter
著者:: Dayana Castillo Seoane, 等
出版事項: (2022-10-01)
著者:: Dayana Castillo Seoane, 等
出版事項: (2022-10-01)
Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
著者:: Hiroki Kato, 等
出版事項: (2021-07-01)
著者:: Hiroki Kato, 等
出版事項: (2021-07-01)
Targeted alpha-particle therapy in neuroendocrine neoplasms: A systematic review
著者:: Thuan Koh, 等
出版事項: (2021-10-01)
著者:: Thuan Koh, 等
出版事項: (2021-10-01)
Empleo de 225Ac y 213Bi como radioisótopos en la terapia alfa dirigida para tratamiento de cáncer
著者:: Vanessa Mayorga-Martino, 等
出版事項: (2022-12-01)
著者:: Vanessa Mayorga-Martino, 等
出版事項: (2022-12-01)
Engineering a Radiohybrid PSMA Ligand with an Albumin-Binding Moiety and Pharmacokinetic Modulation via an Albumin-Binding Competitor for Radiotheranostics
著者:: Saki Hirata, 等
出版事項: (2025-06-01)
著者:: Saki Hirata, 等
出版事項: (2025-06-01)
Targeted Alpha Therapy: Exploring the Clinical Insights into [225Ac]Ac-PSMA and Its Relevance Compared with [177Lu]Lu-PSMA in Advanced Prostate Cancer Management
著者:: Wael Jalloul, 等
出版事項: (2025-08-01)
著者:: Wael Jalloul, 等
出版事項: (2025-08-01)
Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha-emitter radiopharmaceutical therapy of patients with hematological malignancies: a pharmacokinetic modeling analysis
著者:: George Sgouros, 等
出版事項: (2021-08-01)
著者:: George Sgouros, 等
出版事項: (2021-08-01)
In vivo stable 211At-labeled prostate-specific membrane antigen-targeted tracer using a neopentyl glycol structure
著者:: Hiroyuki Suzuki, 等
出版事項: (2024-06-01)
著者:: Hiroyuki Suzuki, 等
出版事項: (2024-06-01)
Actinium-225 in Targeted Alpha Therapy
著者:: A. K. M. Rezaur Rahman, 等
出版事項: (2024-06-01)
著者:: A. K. M. Rezaur Rahman, 等
出版事項: (2024-06-01)
Alpha-Emitting Radionuclides: Current Status and Future Perspectives
著者:: Matthias Miederer, 等
出版事項: (2024-01-01)
著者:: Matthias Miederer, 等
出版事項: (2024-01-01)
Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [225Ac]Ac-DOTA-TDA-Lipiodol® against hepatic tumors
著者:: Anders Josefsson, 等
出版事項: (2023-08-01)
著者:: Anders Josefsson, 等
出版事項: (2023-08-01)
Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics
著者:: Yuta Kaizuka, 等
出版事項: (2024-02-01)
著者:: Yuta Kaizuka, 等
出版事項: (2024-02-01)
Development and Utility of an Imaging System for Internal Dosimetry of Astatine-211 in Mice
著者:: Atsushi Yagishita, 等
出版事項: (2023-12-01)
著者:: Atsushi Yagishita, 等
出版事項: (2023-12-01)
Surface Adsorption of the Alpha-Emitter Astatine-211 to Gold Nanoparticles Is Stable In Vivo and Potentially Useful in Radionuclide Therapy
著者:: Emanuel Sporer, 等
出版事項: (2021-10-01)
著者:: Emanuel Sporer, 等
出版事項: (2021-10-01)
Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectives
著者:: Eline L. Hooijman, 等
出版事項: (2024-02-01)
著者:: Eline L. Hooijman, 等
出版事項: (2024-02-01)
Production of 211At and automated radiosynthesis of [211At]MABG via electrophilic astatodesilylation
著者:: Yuto Kondo, 等
出版事項: (2025-08-01)
著者:: Yuto Kondo, 等
出版事項: (2025-08-01)
Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model
著者:: Robin I. J. Merkx, 等
出版事項: (2022-05-01)
著者:: Robin I. J. Merkx, 等
出版事項: (2022-05-01)
212Pb in targeted radionuclide therapy: a review
著者:: Jarred Michael Scaffidi-Muta, 等
出版事項: (2025-07-01)
著者:: Jarred Michael Scaffidi-Muta, 等
出版事項: (2025-07-01)
Brain intratumoural astatine-211 radiotherapy targeting syndecan-1 leads to durable glioblastoma remission and immune memory in female miceResearch in context
著者:: Loris Roncali, 等
出版事項: (2024-07-01)
著者:: Loris Roncali, 等
出版事項: (2024-07-01)
Real-time trajectory imaging of alpha particles emitted from actinium-225 and its daughter radionuclides
著者:: Seiichi Yamamoto, 等
出版事項: (2025-01-01)
著者:: Seiichi Yamamoto, 等
出版事項: (2025-01-01)
Quantitative SPECT/CT imaging of actinium-225 for targeted alpha therapy of glioblastomas
著者:: Monika Tulik, 等
出版事項: (2024-05-01)
著者:: Monika Tulik, 等
出版事項: (2024-05-01)
Development of [225Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration
著者:: Ashleigh Hull, 等
出版事項: (2023-09-01)
著者:: Ashleigh Hull, 等
出版事項: (2023-09-01)
Ac-EAZY! Towards GMP-Compliant Module Syntheses of <sup>225</sup>Ac-Labeled Peptides for Clinical Application
著者:: Marc Pretze, 等
出版事項: (2021-07-01)
著者:: Marc Pretze, 等
出版事項: (2021-07-01)
Daratumumab-225Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors
著者:: Wojciech Dawicki, 等
出版事項: (2019-08-01)
著者:: Wojciech Dawicki, 等
出版事項: (2019-08-01)
Evaluation of Actinium-225 Labeled Minigastrin Analogue [<sup>225</sup>Ac]Ac-DOTA-PP-F11N for Targeted Alpha Particle Therapy
著者:: Yun Qin, 等
出版事項: (2020-11-01)
著者:: Yun Qin, 等
出版事項: (2020-11-01)
Locoregional radionuclide therapy of glioblastoma with [211At]At-PDA-FAPI
著者:: Huan Ma, 等
出版事項: (2025-05-01)
著者:: Huan Ma, 等
出版事項: (2025-05-01)
Pretargeted Alpha Therapy of Disseminated Cancer Combining Click Chemistry and Astatine-211
著者:: Chiara Timperanza, 等
出版事項: (2023-04-01)
著者:: Chiara Timperanza, 等
出版事項: (2023-04-01)
Efficacy and Safety of Radioligand Therapy with Actinium-225 DOTATATE in Patients with Advanced, Metastatic or Inoperable Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
著者:: Alessio Rizzo, 等
出版事項: (2025-07-01)
著者:: Alessio Rizzo, 等
出版事項: (2025-07-01)
[225Ac]Ac-PSMA-617 production method: development of an efficient and reproducible radiolabelling process for establish a clinical routine production
著者:: Michela Aurilio, 等
出版事項: (2025-05-01)
著者:: Michela Aurilio, 等
出版事項: (2025-05-01)
Hematological toxicity of [225Ac]Ac-PSMA-617 and [177Lu]Lu-PSMA-617 in RM1-PGLS syngeneic mouse model
著者:: Meryl Maria Vilangattil, 等
出版事項: (2025-03-01)
著者:: Meryl Maria Vilangattil, 等
出版事項: (2025-03-01)
Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review
著者:: Sipho Mdanda, 等
出版事項: (2023-06-01)
著者:: Sipho Mdanda, 等
出版事項: (2023-06-01)
A Monte Carlo Method for Determining the Response Relationship between Two Commonly Used Detectors to Indirectly Measure Alpha Particle Radiation Activity
著者:: Christopher J. Tichacek, 等
出版事項: (2019-09-01)
著者:: Christopher J. Tichacek, 等
出版事項: (2019-09-01)
Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?
著者:: Roger M. Pallares, 等
出版事項: (2022-12-01)
著者:: Roger M. Pallares, 等
出版事項: (2022-12-01)
PARP1-targeted alpha therapy enhances target expression
著者:: Hasan Babazada, 等
出版事項: (2025-06-01)
著者:: Hasan Babazada, 等
出版事項: (2025-06-01)
Production of [211At]NaAt solution under GMP compliance for investigator-initiated clinical trial
著者:: Sadahiro Naka, 等
出版事項: (2024-04-01)
著者:: Sadahiro Naka, 等
出版事項: (2024-04-01)
Corrosion behavior of iron-chrome alloys in liquid bismuth
著者:: Toshihide TAKAI, 等
出版事項: (2022-08-01)
著者:: Toshihide TAKAI, 等
出版事項: (2022-08-01)
類似資料
-
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”
著者:: Romain Eychenne, 等
出版事項: (2021-06-01) -
Editorial: Targeted alpha particle therapy in oncology
著者:: Øyvind Sverre Bruland, 等
出版事項: (2023-03-01) -
Astatine-211 and actinium-225: two promising nuclides in targeted alpha therapy
著者:: Zuo Dashan, 等
出版事項: (2024-11-01) -
Targeted Alpha Therapy: Progress in Radionuclide Production, Radiochemistry, and Applications
著者:: Bryce J. B. Nelson, 等
出版事項: (2020-12-01) -
Gamma counting protocols for the accurate quantification of 225Ac and 213Bi without the need for a secular equilibrium between parent and gamma-emitting daughter
著者:: Dayana Castillo Seoane, 等
出版事項: (2022-10-01)
